| P2093 | author name string | M Maeda | |
| | N Yamamoto | |
| | K Fujisawa | |
| | T Matsumoto | |
| | K Matsuura | |
| | I Hidaka | |
| | T Takami | |
| | I Sakaida | |
| | I Saeki | |
| | T Hisanaga | |
| P2860 | cites work | Mesenchymal stem cell therapy for liver fibrosis | Q26782128 |
| | Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes | Q27026108 |
| | Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy | Q28246439 |
| | Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 |
| | Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 |
| | The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 |
| | Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy | Q33676440 |
| | Mesenchymal stem cells can participate in ischemic neovascularization | Q33886115 |
| | Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition | Q34405052 |
| | Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system | Q35588431 |
| | Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma | Q35731845 |
| | Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features | Q35984383 |
| | Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells | Q36090832 |
| | Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1. | Q36523877 |
| | Stem cell recruitment after injury: lessons for regenerative medicine | Q36599286 |
| | Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis | Q36620495 |
| | Concise review: adult multipotent stromal cells and cancer: risk or benefit? | Q37128260 |
| | Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells. | Q37134576 |
| | Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects | Q37190486 |
| | Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study | Q37362580 |
| | Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system | Q37824547 |
| | Role of tumor-associated macrophages in the progression of hepatocellular carcinoma | Q37960792 |
| | Liver from bone marrow in humans. | Q38464633 |
| | High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer. | Q38748794 |
| | Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells | Q38835109 |
| | MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis | Q38927953 |
| | Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. | Q38934719 |
| | Effect of bone marrow-derived mesenchymal stromal cells on hepatoma. | Q38978931 |
| | Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation | Q39166719 |
| | Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells | Q39333106 |
| | Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model | Q39869090 |
| | Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 |
| | Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model | Q39998770 |
| | Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma | Q41488328 |
| | Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis | Q42173543 |
| | Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages | Q42253863 |
| | Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells | Q44036647 |
| | Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow | Q44286264 |
| | Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis | Q44688428 |
| | Hypoxia-inducible factor–dependent breastcancer–mesenchymal stem cell bidirectional signaling promotesmetastasis. | Q45745286 |
| | Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages | Q46869523 |
| | Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a. | Q47633445 |
| | Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion | Q48217983 |
| | Mesenchymal stem cell therapy of hepatocellular carcinoma in rats: Detection of cell homing and tumor mass by magnetic resonance imaging using iron oxide nanoparticles. | Q48511357 |
| | M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway | Q49255236 |
| | Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. | Q50502635 |
| | Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. | Q50791780 |
| | The distinct roles of mesenchymal stem cells in the initial and progressive stage of hepatocarcinoma. | Q54263670 |
| | Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. | Q54498583 |
| | Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis | Q58862703 |
| | Mesenchymal stem cells enhance growth and metastasis of colon cancer | Q84233035 |
| | CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma | Q88474224 |
| P433 | issue | 3 | |
| P921 | main subject | liver cirrhosis | Q147778 |
| | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 925-935 | |
| P577 | publication date | 2019-04-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis | |
| P478 | volume | 51 | |